European Wound Dressing Market Valued at $4,177.7 million in 2025, Set to Grow at a 3.9% CAGR

European wound dressing market was valued at $4,177.7 million in 2025 and is projected to reach $ 6,050.8 million by 2035, growing at a CAGR of 3.9% during the forecast Period (2026-2035). Recent approvals of advanced wound care technologies are accelerating adoption in healthcare facilities, supporting market growth in Europe by enabling more effective management of chronic wounds. These developments reflect the increasing focus on innovations that improve healing outcomes and reduce healthcare burdens. For instance, in September 2025, Convatec received regulatory approval for ConvaMatrix, a porcine placenta-derived skin substitute designed to aid the healing of hard-to-heal wounds such as venous leg ulcers and diabetic foot ulcers. This innovative, single-use wound dressing will be launched in the UK and Europe starting in 2026, providing significant health benefits for patients and healthcare professionals. The approval of ConvaMatrix follows a series of other regulatory approvals for Convatec's wound care technologies in the past year, reinforcing the company's commitment to improving care for chronic wounds.

Browse the full report description of “European Wound Dressing Market Size, Share & Trends Analysis Report by Type (Advanced Wound Dressing and Traditional Wound Dressing), by Application (Burn, Ulcer, Surgical Wound, and Traumatic Wound), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/european-wound-dressing-market

New Advances in New Fast-Application Wound Therapy Dressing

• In June 2025, a wound dressing named ConvaNioX has been approved for use in Europe by Barts Health. It offers a new solution for individuals with hard-to-heal and infected wounds by releasing nitric oxide, which aids in fighting infection and promoting tissue healing.
• In February 2025, MediWound launched the Phase III VALUE trial to assess the bioactive debridement therapy, EscharEx, for venous leg ulcers at 40 sites in Europe and the US. This multicentre, adaptive, double-blind, placebo-controlled trial will evaluate the therapy's safety and efficacy for debridement and wound preparation. Co-primary endpoints include complete debridement and wound closure, with secondary endpoints on granulation tissue and wound area changes. The trial involves collaboration with Solventum, MIMEDX, and Mölnlycke for consistent wound management.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
• Competitive Landscape - Coloplast, ConvaTec Group, Mölnlycke Health Care AB, PAUL HARTMANN AG, Smith & Nephew

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Wound Dressing Market Report Segment

By Type

• Advanced Wound Dressing
  • Alginates Dressing
  • Collagen Dressing
  • Hydrocolloids Dressing
  • Hydrogels Dressing
  • Other Dressing
• Traditional Wound Dressing
  • Gauze
  • Lint
  • Wadding
  • Plasters
  • Others

By Application

• Burn
• Ulcer
  • Diabetic Foot Ulcer
  • Pressure Ulcer
  • Venous Ulcer
• Surgical Wound
• Traumatic Wound

European Wound Dressing Market Report Segment by Region

European

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of European

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-wound-dressing-market